Search - tctmd.com

Displaying 401 - 420 of 1231

Sort: Relevancy | Date

News Industry News

Ventrix Initiates Clinical Trial of VentriGel™

September 17, 2015

News Industry News

Thoratec trial pits HeartMate PHP against Abiomed’s Impella

September 04, 2015

News Conference News ESC 2015

UK Registry: No Relationship Between Hospital PCI Volume and Early Mortality

Yael L. Maxwell

September 01, 2015

News Industry News

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

August 27, 2015

News Daily News

美国的女性介入医生依然很罕见

Yael L. Maxwell

August 21, 2015

News Daily News

Las Mujeres Intervencionistas Siguen Siendo una Rareza en EE.UU.

Yael L. Maxwell

August 21, 2015

News Daily News

Female Interventionalists Remain a Rarity in the United States

Yael L. Maxwell

August 21, 2015

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

News Daily News

El Estudio BRAIN Confirma una Mayor Dosis de Radiación en el Lado Izdo. de los Cardiólogos

Yael L. Maxwell

August 19, 2015

News Daily News

BRAIN 研究证实心脏病科医生左侧接受的放射剂量更多

Yael L. Maxwell

August 19, 2015

News Daily News

BRAIN Study Confirms Higher Radiation Dose to Cardiologists’ Left Side

Yael L. Maxwell

August 19, 2015

News Industry News

Corindus Vascular Robotics and Unfors RaySafe Partner to Protect Against Physician and Staff Radiation Exposure in the Cath Lab

August 18, 2015

Presentation

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

Presenter: BM. Everett BM

August 14, 2015

News Daily News

International Study Links Treatment Variations to Mortality in Acute MI

Yael L. Maxwell

August 14, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

BARI 2D: El Mayor Control de los Factores de Riesgo en Pacientes con Diabetes Tipo 2 Mejora Supervivencia

Yael L. Maxwell

August 12, 2015

News Daily News

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Yael L. Maxwell

August 12, 2015

Presentation

Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial

Presenter: Vera Bittner

August 11, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

Advertisement

Ventrix Initiates Clinical Trial of VentriGel™

Thoratec trial pits HeartMate PHP against Abiomed’s Impella

UK Registry: No Relationship Between Hospital PCI Volume and Early Mortality

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

美国的女性介入医生依然很罕见

Las Mujeres Intervencionistas Siguen Siendo una Rareza en EE.UU.

Female Interventionalists Remain a Rarity in the United States

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

El Estudio BRAIN Confirma una Mayor Dosis de Radiación en el Lado Izdo. de los Cardiólogos

BRAIN 研究证实心脏病科医生左侧接受的放射剂量更多

BRAIN Study Confirms Higher Radiation Dose to Cardiologists’ Left Side

Corindus Vascular Robotics and Unfors RaySafe Partner to Protect Against Physician and Staff Radiation Exposure in the Cath Lab

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

International Study Links Treatment Variations to Mortality in Acute MI

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

BARI 2D: El Mayor Control de los Factores de Riesgo en Pacientes con Diabetes Tipo 2 Mejora Supervivencia

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content